Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This reduces calcium entry into neurons, limiting the release of excitatory neurotransmitters and thereby decreasing abnormal neuronal firing that contributes to seizures and neuropathic pain.

The appropriate dose of Neurontin is individualized by the prescribing clinician based on the patient’s medical condition, renal function, age, and response to therapy. Dosage adjustments may be required for patients with impaired kidney function.

Safety data for gabapentin in pregnancy are limited, and the drug is classified as pregnancy category unknown. It should be used only if the potential benefit justifies any potential risk to the fetus. Caution is also advised during breastfeeding, as the medication can be excreted in breast milk.

To order Neurontin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Both gabapentin (Neurontin) and pregabalin belong to the same class of calcium‑channel modulators and are used for neuropathic pain and seizures. Pregabalin generally has higher bioavailability and may require fewer daily doses, while gabapentin is often less expensive and has a longer history of use. Clinical choice depends on efficacy, tolerability, cost and patient-specific factors.

Neurontin tablets should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and store it out of reach of children.

Neurontin is taken orally as a tablet. Patients should swallow the tablet whole with water, with or without food, as directed by their healthcare provider. The dosing schedule (once, twice, or three times daily) is determined by the prescriber.

Serious risks include the development of suicidal thoughts or behavior, severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, angioedema, and rare hematologic abnormalities. Patients should seek immediate medical attention if they notice rash, swelling, or mood changes.

Neurontin should be avoided in patients with known hypersensitivity to gabapentin or any of its excipients. It is also contraindicated in individuals with severe renal impairment unless dose adjustments are made, and it should be used with caution in patients with a history of depression or suicidal ideation.